Pharma & Biotech

Eli Lilly finds itself navigating regulatory challenges as the U.S. Food and Drug Administration takes issue with the pharmaceutical giant's...

Bayer's preferred shares (BAYN.DE) demonstrated modest resilience in Thursday's trading session, closing at $8.08 with a slight gain of 0.12%....

While many stocks struggle during periods of market uncertainty, Elanco Animal Health Incorporated is demonstrating remarkable resilience. The animal health...

Integra LifeSciences presents a compelling case study in corporate resilience, where robust operational performance is being severely tested by a...

The stock of telehealth company Hims & Hers Health, Inc. experienced a period of significant volatility after receiving a formal...

While market experts maintain highly optimistic projections for Actinium Pharmaceuticals' development pipeline, the company's shares continue to experience significant downward...

The German biotechnology firm BioNTech is generating significant attention with compelling new clinical trial results for an investigational cancer vaccine....

Iovance Biotherapeutics shares are experiencing significant downward pressure after the company's latest quarterly results fell short of market expectations. The...

Shares of telehealth provider Hims & Hers Health faced significant pressure this week following a regulatory confrontation with the U.S....

Lyell Immunopharma has initiated its crucial Phase 3 clinical trial, named PiNACLE - H2H, for its next-generation CAR T-cell therapy...